SCHEMBL4029375

SCHEMBL4029375

Cc1oc(-c2ccccc2)nc1CCOc1ccc(CCl)cc1

nearest known ligand 0.71

Predicted protein targets (top 3)

geneUniProtsupporting neighboursconfidence
PPARG P37231 20/20 0.71
PPARA Q07869 16/20 0.71
PPARD Q03181 8/20 0.66

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3279259 0.89 PPARG (0.72) PPARGPPARAPPARD
SCHEMBL4389208 0.88 PPARG (0.79) PPARGPPARAPPARD
SCHEMBL16144192 0.88 PPARG (0.71) PPARGPPARAPPARD
SCHEMBL14382549 0.88 PPARG (0.71) PPARGPPARAPPARD
SCHEMBL3279660 0.88 PPARG (0.71) PPARGPPARAPPARD
SCHEMBL9537307 0.88 PPARG (0.71) PPARGPPARAPPARD
SCHEMBL4035773 0.88 FFAR1 (0.69) PPARGPPARAPPARD
SCHEMBL3283978 0.87 PPARG (0.77) PPARGPPARAPPARD
SCHEMBL5112238 0.86 PPARG (0.76) PPARGPPARAPPARD
SCHEMBL5098728 0.86 PPARG (0.76) PPARGPPARAPPARD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 36 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1357115-B1 ALKANOIC ACID DERIVATIVES, PROCESS FOR THEIR PRODUCTION AND USE THEREOF TAKEDA PHARMACEUTICAL (JP) 2009-06-17 EP disclosed
US-7241785-B2 Five-membered heterocyclic alkanoic acid derivative TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2007-07-10 US disclosed
US-7238716-B2 Alkanoic acid derivatives process for their production and use thereof TAKEDA PHARMACEUTICALS COMPANY LIMITED (JP) 2007-07-03 US disclosed
US-7179823-B1 5-membered n-heterocyclic compounds with hypoglycemic and hypolipidemic activity TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2007-02-20 US disclosed
EP-1577305-A1 Oral antidiabetic agents WARNER-LAMBERT COMPANY LLC (US) 2005-09-21 EP disclosed
US-6924300-B2 Oxyiminoalkanoic acid derivatives TAKEDA CHEMICAL INDUSTRIES, LTD. (JP) 2005-08-02 US disclosed
EP-1457490-A1 5-membered N-heterocyclic compounds with hypoglycemic and hypolipidemic activity Takeda Chemical Industries, Ltd. (JP) 2004-09-15 EP disclosed
EP-1077957-B1 OXYIMINOALKANOIC ACID DERIVATIVES WITH HYPOGLYCEMIC AND HYPOLIPIDEMIC ACTIVITY TAKEDA CHEMICAL INDUSTRIES LTD (JP) 2004-08-04 EP disclosed
EP-1228067-B1 5-MEMBERED N-HETEROCYCLIC COMPOUNDS WITH HYPOGLYCEMIC AND HYPOLIPIDEMIC ACTIVITY TAKEDA CHEMICAL INDUSTRIES LTD (JP) 2004-07-14 EP disclosed
EP-1428531-A1 Oxyiminoalkanoic acid derivatives with hypoglycemic and hypolipidemic activity TAKEDA CHEMICAL INDUSTRIES, LTD. (JP) 2004-06-16 EP disclosed
US-6037359-A ARTERIOSCLEROSIS PREVENTION; ANTIDIABETIC AGENTS; ANTILIPEMIC AND HYPOGLYCEMIC AGENTS JAPAN TOBACCO, INC. (JP) 2000-03-14 US disclosed
WO-1999058510-A1 OXYIMINOALKANOIC ACID DERIVATIVES WITH HYPOGLYCEMIC AND HYPOLIPIDEMIC ACTIVITY TAKEDA CHEMICAL INDUSTRIES, LTD. (JP) 1999-11-18 WO disclosed
EP-0684242-B1 ISOXAZOLIDINEDIONE DERIVATIVE AND USE THEREOF JAPAN TOBACCO INC (JP) 1999-05-06 EP disclosed
US-5591862-A ANTILIPEMICS, TREATING DIABETES TAKEDA CHEMICAL INDUSTRIES, LTD. (JP) 1997-01-07 US disclosed
US-5498621-A Oxazolidinedione hypoglycemic agents PFIZER INC. (US) 1996-03-12 US disclosed
EP-0684242-A1 ISOXAZOLIDINEDIONE DERIVATIVE AND USE THEREOF JAPAN TOBACCO INC. (JP) 1995-11-29 EP disclosed
EP-0428312-B1 Oxazolidinedione hypoglycemic agents PFIZER (US) 1994-12-28 EP disclosed
EP-0629624-A1 Tetrazole derivatives, their production and use TAKEDA CHEMICAL INDUSTRIES, LTD. (JP) 1994-12-21 EP disclosed
WO-1991007107-A1 OXAZOLIDINEDIONE HYPOGLYCEMIC AGENTS PFIZER INC. (US) 1991-05-30 WO disclosed
EP-0428312-A2 Oxazolidinedione hypoglycemic agents PFIZER INC. (US) 1991-05-22 EP disclosed